Explore more Johnson & Johnson sites:
Share
Back to top
Heart disease
-
In many cases, it can take more than two years to diagnose this rare disease—and that delay can be deadly. Johnson & Johnson is on a mission to identify patients earlier by harnessing the power of artificial intelligence, smartphone apps and more.
-
Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.
-
Imagine having a disease that many doctors have never seen before. That's what Marty Verel experienced when he was told he had AL amyloidosis—and it's what hematologist Brendan Weiss, M.D., is determined to help change. For Amyloidosis Awareness Month, Dr. Weiss shares what he's learned studying the rare disease.
-
Black people are far more likely to live with cardiovascular diseases than other populations in the United States. We spoke to three experts about the consequences of that disparity—and how Johnson & Johnson is actively working to help drive change and better heart health through improved education, diagnosis and treatment.
-
From churches to schools—and even roving healthcare vans—the company has rolled out a program in states across the nation to help get COVID-19 testing and other crucial health services to underserved communities.
-
Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.
-
Have you been putting off medical care this year out of concern about COVID-19? We asked a triple board-certified physician to share his best advice—and info about a new digital resource called My Health Can't Wait—for how to ensure you aren't putting your health at risk by waiting to schedule healthcare visits.
-
In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.
-
Some 33 million people worldwide have atrial fibrillation, a form of heart disease that can lead to stroke. Are you at risk? For AFib Awareness Month, take this quiz to test your AFib know-how.
-
The heart condition affects up to six million Americans, and raises the risk of stroke five-fold. One patient describes what it was like to learn she had atrial fibrillation—and the unexpected positive impact it has had on her life.
-
Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.
-
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
-
If getting healthy is one of your resolutions—and you’ve wondered about bariatric surgery—here are answers to some common questions, including what BMI you really need to have to qualify for the procedure and whether you can expect to gain any weight back.
-
It's one hard-working organ, pumping 1.5 gallons of blood every minute and beating around 100,000 times a day. In honor of Pulmonary Hypertension Awareness Month, we sat down with a ticker expert to learn about things most people may not know about their hearts—and advances that could change cardiac care.
-
Your DNA doesn’t have to determine your medical future if you consider taking some steps to help lower your chances of developing these conditions, which tend to have genetic ties.
